Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Yamamoto
Christopher Yamamoto
University of California, Los Angeles
Physical therapy
Medicine
Immune system
Adverse effect
Clinical trial
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use of immune checkpoint inhibitors in a community practice within a vertically integrated health care system.
2018
Journal of Clinical Oncology
Robert Michael Cooper
Christopher Yamamoto
Thach-Giao Truong
Fang Niu
Helen Moon
Michele M. Spence
Jim Chan
Timothy Chiu
Rita L. Hui
Show All
Source
Cite
Save
Citations (0)
Immune-related adverse events (IrAE) of elderly patients (pts) receiving PD-1 or PDL-1 inhibitors (PDIs) in a community-oncology setting: The experience at Kaiser Permanente California.
2018
Journal of Clinical Oncology
Thach-Giao Truong
Christopher Yamamoto
Timothy Chiu
Fang Niu
Michele M. Spence
Jim Chan
Robert Michael Cooper
Helen Moon
Rita L. Hui
Show All
Source
Cite
Save
Citations (2)
Immune-related adverse events (IRAE) of elderly patients (PTS) with advanced melanoma (AMEL) treated with checkpoint inhibitors (CI) in a community setting: The experience (EXP) at Kaiser Permanente (KP) California.
2018
Journal of Clinical Oncology
Thach-Giao Truong
Helen Moon
Timothy Chiu
Christopher Yamamoto
Michele M. Spence
Juraj Kavecansky
Fang Niu
Rita L. Hui
Show All
Source
Cite
Save
Citations (0)
1